Skip to main navigation Skip to search Skip to main content

Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892–1901, (S0264410X23001317), (10.1016/j.vaccine.2023.02.005)]

  • Hye Won Kwak
  • , Hyo Jung Park
  • , Seo Yeon Jung
  • , Eun Young Oh
  • , Sang In Park
  • , Yeonhwa Kim
  • , Hyeong Jun Park
  • , Sohyun Park
  • , You Jin Kim
  • , Hae Li Ko
  • , Jung Ah Lee
  • , Hyeran Won
  • , Yun Ho Hwang
  • , Seo Yeon Kim
  • , Se Eun Kim
  • , Seong Eun Bae
  • , Minhyuk Yoon
  • , Jae Ouk Kim
  • , Manki Song
  • , Su Jeen Lee
    • Ki Weon Seo, Kunse Lee, Dokeun Kim, Hun Kim, Sang Myeong Lee, So Hee Hong, Jae Hwan Nam
  • The Catholic University of Korea
  • SML Biopharm
  • SK Bioscience
  • Chungbuk National University
  • Scripps Korea Antibody Institute
  • Korea National Institute of Health
  • International Vaccine Institute, Seoul
  • Ewha Womans University

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants” [Vaccine 41(11) (2023) 1892–1901, (S0264410X23001317), (10.1016/j.vaccine.2023.02.005)]'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry